PERSPECTA

News from every angle

Back to headlines

Aspire Biopharma authorizes $5M share repurchase program

Aspire Biopharma (ASBP) has authorized a share repurchase program valued at $5 million, signaling a move to buy back its own stock.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.